Pathology Lecture Series
Pathology Lecture Series
Pathology Lecture Series
SERIES
Butch Dumdum
Outline
Day 1 (General Pathology)
Introduction, Cellular Adaptation,Tissue Injury
Inflammation (Acute and Chronic)
Hemostasis,Thrombosis, and Infarct
Neoplasia
Pathology
Definition
Pathology is the study (logos) of
suffering/diseases (pathos)
Involves basic medical sciences and
clinical practice to investigates of the
causes (etiology) of the diseases and
the mechanism (pathogenesis)
Basic terminology in
Pathology
Disease
Etiology
Pathogenesis
Diagnosis
Clinical manifestation - Signs and
symptoms
Prognosis
Epidemiology
5
Disease / dis-ease
Disease is a condition in which the presence of
an abnormality of the body causes a loss of
normal health
Idiopathic no identifiable causes
Iatrogenic occur as a result from medical
treatment
Congenital disease existing at birth or before
birth, involves in the development of fetus
Acquired - develops post fetally
Nosocomial due to being in a hospital
environments
6
Etiology
Refers to the study of the cause of
the disease
General categories of etiological
agents; genetic abnormalities,
infective agents, chemical, radiation,
mechanical trauma, malnutrition
Pathogenesis
Is a mechanism of the disease which
etiology operates to produce the
pathological and clinical
manifestation
For examples inflammation,
degeneration, immune response
Diagnosis
Refers to the process of attempting to
determine or identify a possible disease
or disorder.
Prognosis
Refers to the expected outcome of a
disease.
9
10
Clinical Manifestation
Are the signs and symptoms or
evidence of disease
Signs objective alteration that can
be observe or measured by another
person; pulse rate, blood pressure,
Temperature etc
Symptoms subjective experiences
reported by the person, complains
such as pain, nausea, vomiting etc
11
Epidemiology
Is the study of tracking patters of
disease occurrence and transmission
among populations and by
geographic areas.
Incidence of a disease is the number
of new cases occurring in specific
time of period
Prevalence of a disease is the
number of existing cases within a
populations during the specific time
12
2. Hepatosplenomegaly
Root : hepato (hepar), spleno (spleen)
Suffix : -megaly (enlargement)
3. Meningitis
Root : mening (meninges)
Suffix : - itis (inflammation)
4. Tachycardia
Root : cardia (heart)
Prefix : tachy (fast/rapid)
14
NORMAL
CELLS
Injurie
s
CELLS
DEGENERATION
Injuries
CELLS DEATH
(NECROSIS/APOPTOSI
S
15
Cellular Adaptation
Under normal conditions, cells must
constantly adapt to changes is their
environment (physiological,
pathological).
Atrophy
Hypertrophy
Hyperplasia
Dysplasia
Metaplasia
16
Atrophy
17
Hypertrophy
Increase the size of the
cells and consequently
the size of the organs
Increased the synthesis
of structural protein and
organelles
Can be physiologic
(ex;increase workload
during exercise, uterine
myometrium during
pregnancy) and
pathologic (hypertrophy
of myocardium
hypertension/aortic
valve disease)
18
Hyperplasia
Increase the number of
cells in an organ or tissue.
(increase rate of cellular
division)
Hypertrophy and
hyperplasia are closely
related (exp : gravid
uterus)
Can be compensatory
hyperplasia (exp: liver),
hormonal hyperplasia
(exp: uterus, breast) and
pathological (exp:
endometrium)
19
Metaplasia
Is a reversible change in which one adult cell type
is replaced by another cell type.
Adaptation of cells that sensitive to particular
stress to cell types better able to withstand the
adverse of environment
20
21
Dysplasia
Not a true cellular
adaptation
Atypical hyperplasia
Abnormal change in the
size, shape and
organization of mature
cells
Strongly associated with
common neoplastic
growth
Exp: CIN cervical
intraepithelial neoplasia,
hip dysplasia
22
23
Cell Injury
Nonlethal injury - cell degeneration
Lethal injury necrosis
24
Stages of Necrosis
Early changes : morphologically normal
Nuclear changes : pyknosis chromatin
clumps into coarse strands, nucleus
become shrunken
Cytoplasmic changes : denaturation of
cytoplasmic protein and lost of
ribosomes, swelling of mitochondria and
disruption of organelle membranes and
autolysis occur via lysosomes
27
Type of Necrosis
Different cells shows different
morphologic changes after they undergo
necrosis. Base on that necrosis can be
classified into:
1. Coagulative necrosis
2. Liquefactive necrosis
3. Caseous / gummatous necrosis
4. Fat necrosis
5. Gangrenous Necrosis
29
Coagulative Necrosis
Typically occur in solid organ; heart, kidney, adrenal
glands
Due to hypoxia (maybe from severe ischemia or
chemical)
Normally, this necrotic cells retains its cellular outline.
Denaturation of protein albumin causes coagulation.
30
Liquefactive Necrosis
Normally occurs in CNS
which affects neuron
and neuroglia cells
Associated with focal
bacterial and fungus
infections
The affected cells
completely digest by
hydrolytic enzymes thus
changes the tissue into
liquid viscous mass.
31
Caseous Necrosis
Caseous cheese
like appearance
Associated with
tuberculous
pulmonary (TB)
infection, esp by
Mycobacterium
Tuberculosis
32
Fat Necrosis
Occur in pancreas, breast and other abdominal structures
Caused by lipases enzymes which break down
triglycerides (lipid) into fatty acids and glycerol
Fatty acids and glycerol then combine with Ca, Mg, Na to
form Calcium Soaps (Saponification)
The necrotic tissue appears opaque and chalk white.
33
Oxygen deprivation
Chemical agents
Infectious agents
Immunologic reactions
Genetic defects
Nutritional imbalances
Physical agents
Aging
35
Oxygen deprivation
Hypoxia oxygen deficiency
Due to ischemia lost/lack of blood
supply (due to arterial blockage or
reduce venous drainage)
Hypoxia also can occurs via:
Lack of oxygen inside blood
Reduction in oxygen carrying capacity in
RBC (anemia)
Carbon monoxide poisoning
36
Chemical agents
Most of the chemical substances can
cause cell injury
For example : poisons, air pollutants,
insecticides, CO, asbestos, ethanol,
therapeutics drugs etc
This agents can cause cell death by:
Altering membrane permeability
Altering osmotic homeostasis
Altering integrity of an enzyme
37
Infectious agent
Viruses, bacteria, fungi, parasites,
helminths
38
Immunologic Reactions
Autoimmune disease immunity
against its own tissues . For
examples SLE, Rheumatoid Arthritis
etc
39
Genetic Defects
Abnormalities to the genomes mutation
This chromosome anomaly is
associated with missing, or
irregularities or extra in portion of
chromosomal DNA
Syndrome Down, Alzheimer's
Disease, Huntingtons Disease etc
40
Nutritional Imbalance
Cause by directly or indirectly lack of
essential nutrients (malnutrition)
Or it maybe related to excessive of
food intake (Diabetic Mellitus)
For example protein deficiency
Kwashiorkor, Marasmus
Calcium deficiency osteoporosis
Vitamin C - Scurvy
41
Physical Agents
Trauma, extremes of temperature,
radiation, electrical shock all have
wide ranging effects on cells.
42
Aging
Aged cells become larger, less able
to divide and multiply
Lose their ability to functions, or
function abnormally.
43
Inflammation
Acute vs Chronic
SEQUENCE OF EVENTS
NORMAL HISTOLOGY
VASODILATATION
INCREASED VASCULAR PERMEABILITY
LEAKAGE OF EXUDATE
MARGINATION, ROLLING, ADHESION
TRANSMIGRATION (DIAPEDESIS)
CHEMOTAXIS
PMN ACTIVATION
PHAGOCYTOSIS: Recognition, Attachment,
Engulfment, Killing (degradation or
digestion)
TERMINATION
100% RESOLUTION, SCAR, or CHRONIC
INFLAMMATION are the three possible
ACUTE
INFLAMMATION
PROTECTIVE
RESPONSE
NON-specific
ACUTE
INFLAMMATION
VASCULAR EVENTS
CELLULAR EVENTS (PMN
or PolyMorphonuclear
Neutrophil, Leukocyte?,
POLY, Neutrophil,
Granulocyte, Neutrophilic
Granulocyte
ACUTE
INFLAMMATION
Neutrophil
Polymorphonuclear
Leukocyte, PMN, PML
Leukocyte
Granulocyte,
Neutrophilic
granulocyte
Poly-
HISTORICAL
HIGHLIGHTS
(Egypt, 3000 BC)
Rubor
Calor
Tumor
Dolor
5th (functio
laesa)
STIMULI
for acute inflammation
INFECTIOUS
PHYSICAL
CHEMICAL
Tissue Necrosis
Foreign Bodies (FBs)
Immune responses, or
complexes
Vascular Changes
Changes in Vascular
Flow and Caliber
Increased Vascular
Permeability
INCREASED
PERMEABILITY
DILATATION
Endothelial gaps
Direct Injury
Leukocyte Injury
Transocytosis
(endo/exo)
LEAKAGE OF
PROTEINACEOUS
FLUID (
EXUDATE,
NOT TRANSUDATE)
EXTRAVASATION of
PMNs
MARGINATION
(PMNs go
toward wall)
ROLLING
(tumbling and
HEAPING)
ADHESION
TRANSMIGRATIO
N (DIAPEDESIS)
ADHESION MOLECULES
(glycoproteins) affecting
ADHESION and TRANSMIGRATION
SECRETINS (from
endothelial cells)
INTEGRINS (from many
cells)
CHEMOTAXIS
PMNs going to the site of
injury
AFTER transmigration
LEUKOCYTE
ACTIVATION
triggered by the offending stimuli for
PMNs to:
1) Produce eicosanoids
(arachidonic acid derivatives)
Prostaglandin (and thromboxanes)
Leukotrienes
Lipoxins
2) Undergo DEGRANULATION
PHAGOCYTOSIS
RECOGNITION
ENGULFMENT
KILLING
(DEGRADATION
/DIGESTION)
CHEMICAL
MEDIATORS
CLASSIC MEDIATORS
HISTAMINE
SEROTONIN
COMPLEMENT
KININS
CLOTTING
FACTORS
EICOSANOIDS
NITRIC OXIDE
PLATELET
ACTIVATING
FACTOR (PAF)
CYTOKINES
/CHEMOKINES
LYSOSOME
CONSTITUENTS
FREE RADICALS
NEUROPEPTIDES
HISTAMINE
Mast Cells,
basophils
POWERFUL
Vasodilator
Vasoactive
amine
IgE on mast
cell
SEROTONIN
(5HT,
5-
HydroxyTryptamine)
Platelets and
EnteroChromaffin
Cells
Also vasodilatation,
but more indirect
Evokes N.O.
synthetase (a
COMPLEMENT
SYSTEM
>20
component
s, in
circulating
plasma
Multiple
sites of
action, but
LYSIS is
the
KININ SYSTEM
BRADYKININ is KEY component, 9
aas
ALSO from circulating plasma
ACTIONS
Increased permeability
Smooth muscle contraction, NON
vascular
PAIN
CLOTTING
FACTORS
Also from circulating plasma
Coagulation, i.e., production
of fibrin
Fibrinolysis
EICOSANOIDS
(ARACHIDONIC ACID DERIVATIVES)
Part of cell
membranes
1) Prostaglandins
(incl.
Thromboxanes)
2)
Leukotrienes
MULTIPLE
ACTIONS AT MANY
Prostaglandins
(thromboxanes included)
Pain
Fever
Clotting
Leukotrienes
Chemotaxis
Vasoconstriction
Increased
Permeability
Lipoxins
INHIBIT chemotaxis
Vasodilatation
Counteract actions
of leukotrienes
Platelet-Activating Factor
(PAF)
Phospholipid
From MANY cells,
like eicosanoids
ACTIVATE
PLATELETS,
powerfully
CYTOKINES/CHEMOKIN
ES
CYTOKINES are PROTEINS produced
by MANY cells, but usually
LYMPHOCYTES and MACROPHAGES,
numerous roles in acute and chronic
inflammation
TNF, IL-1, by
macrophages
NITRIC OXIDE
Potent vasodilator
Produced from the
action of nitric oxide
synthetase from
arginine
LYSOSOMAL
SECONDARY
CONSTITUENTS
PRIMARY
Also called
AZUROPHILIC,
or NONspecific
Myeloperoxida
se
Lysozyme
(Bact.)
Acid
Hydrolases
Also called
SPECIFIC
Lactoferrin
Lysozyme
Alkaline
Phosphatase
Collagenase
FREE RADICALS
O2 (SUPEROXIDE)
H2O2 (PEROXIDE)
OH- (HYDROXYL RADICAL)
VERY VERY
DESTRUCTIVE
NEUROPEPTIDES
Produced in CNS
(neurons)
SUBSTANCE P
NEUROKININ A
OUTCOMES OF
ACUTE INFLAMMATION
1) 100% complete
RESOLUTION
2) SCAR
3)CHRONIC inflammation
Morphologic PATTERNS
of Acute INFLAMMATION
(EXUDATE)
Serous (watery)
Fibrinous
(hemorrhagic, rich in
FIBRIN)
Suppurative (PUS)
FIBRINOUS
PUS
=
PURULEN
T
ABSCESS
=
POCKET
OF
PUS
PURULENT, FIBRINOPURULENT
ULCERATIVE
SEQUENCE OF EVENTS
NORMAL HISTOLOGY
VASODILATATION
INCREASED VASCULAR PERMEABILITY
LEAKAGE OF EXUDATE
MARGINATION, ROLLING, ADHESION
TRANSMIGRATION (DIAPEDESIS)
CHEMOTAXIS
PMN ACTIVATION
PHAGOCYTOSIS: Recognition, Attachment,
Engulfment, Killing (degradation or
digestion)
TERMINATION
100% RESOLUTION, SCAR, or CHRONIC
inflammation
CHRONIC INFLAMMATION
(MONOS)
LYMPHOCYT
MONOCYTE
MACROPHAGE
HISTIOCYTE
CAUSES of
CHRONIC INFLAMMATION
1) PERSISTENCE of
Infection
2) PROLONGED
EXPOSURE to insult
3) AUTO-IMMUNITY
Cellular Players
LYMPHOCYTES
MACROPHAGES
(aka,
HISTIOCYTES)
PLASMA CELLS
EOSINOPHILS
MAST CELLS
MORPHOLOGY
INFILTRATION
TISSUE
DESTRUCTION
HEALING
GRANULOMAS
GRANULOMATOUS INFLAMMATION
4
COMPONENTS
FIBROBLAST
S
LYMPHS
HISTIO
S
GRANULOMAS
GRANULOMATOUS INFLAMMATION
CASEATING (TB)
NON-CASEATING
LYMPHATIC
DRAINAGE
SITE REGIONAL LYMPH
NODES
SYSTEMIC MANIFESTATIONS
(NON-SPECIFIC)
FEVER, CHILLS
C-Reactive Protein (CRP)
Hemostasis,Thrombosis
and Infarct
Thrombosis :
Formation of solid mass in
circulation from the blood
constituents - (Thrombus)
Virchows triad
Endothelial injury.
Alteration in the Blood
flow.
Hypercoagulability of the
Blood.
Prothrombotic factors :
Thromboplastin , von Willebird
factor , Platelet activating
factor , Inhibitor of plasminogen
activator
Role of Platelets
Adhesion
Platelet release reaction
Platelet aggrigation
Coagulation system
Plasma Fibrinogen ------ Fibrin
Intrinsic Pathway
&
Extrinsic Pathway
Morphology
Sites Heart , Arteries,
Veins, Capillaries.
Arterial Thrombi Effect is
Ischemia
Venous Thrombi Effect is
Embolism
Fates of Thrombi
Resolution
Organisation
Propagation
Embolism
Predisposing
factors
:
Genetic Deficiency of
Antithrombin, Protein C and S ,
Fibrinolysis .
Acquired Old age , Prolonged
Bed rest ,Immobilisation , oral
contraceptives , smoking , Trauma
fracture burns , Atherosclerosis ,
Varicose veins, Cancers
NEOPLASIA
Neoplasia:
Willis definition:
A neoplasm is an abnormal mass of tissue, the growth
of which exceeds and is uncoordinated with that of the
normal tissue and persists in the same manner after
cessation of the stimuli which evoked the change
Benign - Malignant
Carcinogen
Initiator + Promotor
C
Inflam
Organ / Tissue
1.Proto-Oncogenes (growth
factors)
2.Growth/Tumor suppressor
genes.
3.Genes controlling Apoptosis.
4.Genes controlling DNA Repair.
RAS
Rb
MYC
p53
Apoptosis
Growth Disorders:
Non neoplastic
(Polyclonal)
Neoplastic
(Monoclonal)
Hyperplasia
Hypertrophy
Aplasia
Atrophy
Metaplasia
Dysplasia
Normal
Adaptation
Benign
Malignant
BENIGN
Well differentiated
Slow growth
Cohesive,
expansile
Capsule
No invasion/infiltration
MALIGNANT
Poorly differentiated
Rapid growth
Non Cohesive,
No capsule
invasion/infiltration
Metastases.
Benign
-
Malignant
Necrosis
117
Oma - Tumour
Carcin-oma Hard Tumour
Sarc-oma - Soft Tumour
Neoplasms Nomenclature:
Cell of Origin
Gland. Epithelium
Lining. Epithelium
Fibroblast
Osteoblast
Chondrocyte
Lipocyte
Smooth muscle
Skeletal muscle
Benign
Adenoma Papilloma -
Malignant
Adencarcinoma
Squamous cell ca.
Fibroma Fibrosarcoma
Osteoma Osteosarcoma
Chondroma
Chondrosarcoma
Lipoma
Liposarcoma
Leiomyoma
Leiomyosarcoma
Rhabdomyoma
Rhabdomyosarcoma
Nomenclature:
exceptions
Cancer Biology
Cancer Biology:
Structure:
Parenchyma Neoplastic cells.
Stroma: Non neoplastic - normal DNA
Features:
Differentiation Maturation of cells.
Rate of Growth Mitotic rate / Ki 67
Local invasion Hemorrhage, necrosis,
destruction
Metastasis Distant Spread.
121
Normal
cell
First
mutation
Second
mutation
Third
mutation
Malignant cells
Fourth or
later
mutation
Neoplasia:
Retrograde evolution!
Cancer
Embryo
Self growth
auto regulation
Limitless potential
Angiogenesis
Evade apoptosis
Invasion & infiltration
C-myc
p53
125
Carcinogenesis)
Undiff. (high
128
Stage
T0 In-situ
T1 Primary site
T2 Sec. Anat. site
T3 Tertiary site
T4 Adjacent
region
T
4
N0 No LN mets.
N1 Primary LN
N2 Seondary LN
T1
N3 Tertiary LN
M
0
No metastases
M
1
Metastases +
Based on - ANATOMY & LYMPHATICS
Pre-Cancer
Cancer
131
Metastasis:
Metastasis:
Pathogenesis:
1. Cell loosening
2. BM degradation
3. Invasion
4. Locomotion
5. BV adhesion
6. Intra-vasation
7. Tumour
embolus
8. Adhesion
9. Extra-vasation
10. Angiogenesis
Cancer Diagnosis:
Cancer.
Cell of origin
Rate of growth
Maturation of cells
Well Mod Poor Un diff.
Stage
Local Invasion
Metastasis
Bronchial Epith.
Mitotic rate grade.
Grade
Differentiation
e.g. Lung
SYSTEMIC PATHOLOGY
Atherosclerosis
Myocardial Infarction
LUNGS
Tuberculosis
ASTHMA
Lung Cancer
GIT
RENAL FAILURE
Skin
Sexually Transmitted
AIDS